Cyclopentolate is a muscarinic receptor antagonist formulated as an ophthalmic solution to induce mydriasis and cycloplegia for refraction testing and ophthalmic examination in paediatric and adult patients. Simson Pharma's Cyclopentolate reference standard and impurities support stringent QC for this direct ocular-contact formulation.
Simson Pharma Global Ltd. (UK) and Simson Pharma Global LLC (USA) supply high-quality Cyclopentolate Reference Standards, pharmacopoeial reference materials, and its related impurities to pharmaceutical manufacturers, CROs, analytical laboratories, universities, and regulatory organizations worldwide. To service the Europe and America market efficiently, Simson Pharma Limited has set up Simson Pharma Global Ltd. in United Kingdom and Simson Pharma Global LLC in USA respectively.
